Moderna’s COVID vaccine — its lone commercial product — has brought in $10.4 billion in revenue this year while Pfizer’s vaccine brought in about $22 billion.

In June, the U.S. Food and Drug Administration added a warning label to both Pfizer and Moderna’s COVID-19 vaccine of its potential risk for individuals to develop myocarditis and pericarditis.

Moderna is not asking that courts take the Pfizer-BioNTech COVID-19 vaccine off the market or to stop future sales, in view of the public need for the vaccines. Moderna and Pfizer's vaccines have ...

The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at rival Pfizer, had told his GSK colleagues about the delay.

Texas AG Sues Pfizer Over Covid Vaccine Effectiveness. ByMolly Bohannon, Former Staff. Molly Bohannon has been a Forbes news reporter since 2023. Nov 30, 2023, 05:39pm EST. Share. Save.

Four years after former President Joe Biden’s Pentagon mandated the COVID-19 vaccination for all Department of Defense (DOD) ...

Key Background. Pfizer and BioNTech announced the results of their Covid vaccine on Nov. 9, 2020, six days after Election Day. Former President Joe Biden was declared the winner of the 2020 ...

Since its initial authorization by FDA in December 2020, the Pfizer-BioNTech COVID-19 vaccine has been administered to more than 1.5 billion people, demonstrated a favorable safety profile in all ...

In January 2022, Pfizer CEO Albert Bourla said the company's two-dose vaccine offered limited or no protection against COVID-19.

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

It argues that Pfizer and BioNtech's vaccine infringes patents Moderna filed between 2010 and 2016 for its messenger RNA or mRNA technology. All three companies' COVID-19 vaccines used mRNA ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday.. A widely ...